Caution urged with repeat sentinel lymph node biopsies [1]

Annals of Oncology

Volumn 13, Issue 12, 2002, Pages 1951-

  Chung, M A ^a   Cady, B ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADULT; AXILLARY LYMPH NODE; CANCER RECURRENCE; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LETTER; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODES; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK ASSESSMENT; SAFETY; SENTINEL LYMPH NODE BIOPSY;

EID: 0036921835     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf317     Document Type: Letter

References (2)

1. Zgajnar J, Gatzemeier W, Costa A. Will the sentinel lymph node (SLN) stand a second time-SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure. Ann Oncol 2001; 12: 723.
2. Cady B. Basic principles in surgical oncology. Arch Surg 1997; 132: 338-346